Instituto de Investigación Biomédica de Salamanca-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2025

  1. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk

    International Journal of Cancer, Vol. 157, Núm. 3, pp. 468-479

2024

  1. Triple negative breast cancer, androgen receptor and other markers. Therapeutic strategies

    Revista de Senologia y Patologia Mamaria, Vol. 37, Núm. 3

2023

  1. Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma

    Biochemical Pharmacology, Vol. 214

2021

  1. Genomic heterogeneity of pancreatic ductal adenocarcinoma and its clinical impact

    Cancers, Vol. 13, Núm. 17

  2. Genomic profiling of sporadic liver metastatic colorectal cancer

    Seminars in Cancer Biology, Vol. 71, pp. 98-108

2020

  1. Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients

    BJS open, Vol. 4, Núm. 3, pp. 524-534

  2. MR- proADM to detect specific types of organ failure in infection

    European Journal of Clinical Investigation, Vol. 50, Núm. 6

2019

  1. Distribution of subsets of blood monocytic cells throughout life

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 1, pp. 320-323.e6

  2. The odd situation of pancreas transplantation in Spain

    Nefrologia, Vol. 39, Núm. 5, pp. 455-457

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

  2. Recurrence of cystic echinococcosis in an endemic area: A retrospective study

    BMC Infectious Diseases, Vol. 17, Núm. 1